Bailey RL et al. |
Randomised controlled trial of single-dose azithromycin in treatment of trachoma. |
1993 |
Lancet |
pmid:8102427
|
Donowitz GR and Earnhardt KI |
Azithromycin inhibition of intracellular Legionella micdadei. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8285604
|
Nahata MC et al. |
Pharmacokinetics of azithromycin in pediatric patients after oral administration of multiple doses of suspension. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8383944
|
Vaara M |
Outer membrane permeability barrier to azithromycin, clarithromycin, and roxithromycin in gram-negative enteric bacteria. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8383945
|
Brown ST et al. |
Azithromycin, rifabutin, and rifapentine for treatment and prophylaxis of Mycobacterium avium complex in rats treated with cyclosporine. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8384809
|
Hammerschlag MR et al. |
Single dose of azithromycin for the treatment of genital chlamydial infections in adolescents. |
1993 |
J. Pediatr. |
pmid:8388950
|
Melski JW et al. |
Primary and secondary erythema migrans in central Wisconsin. |
1993 |
Arch Dermatol |
pmid:8389536
|
Kobrehel G et al. |
9a,11-cyclic carbamates of 15-membered azalides. |
1993 |
J. Antibiot. |
pmid:8407586
|
Bonnet M and Van der Auwera P |
Preincubation of Haemophilus influenzae with subinhibitory concentrations of macrolides: influence on human neutrophil chemiluminescence. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8390808
|
Gordillo ME et al. |
In vitro activity of azithromycin against bacterial enteric pathogens. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8390813
|
Amacher DE et al. |
Preclinical toxicology studies with azithromycin: genetic toxicology evaluation. |
1993 |
Mutat. Res. |
pmid:7685497
|
Blais J et al. |
Inhibition of Toxoplasma gondii protein synthesis by azithromycin. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8215287
|
Dever LL et al. |
Comparative in vitro activities of clarithromycin, azithromycin, and erythromycin against Borrelia burgdorferi. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8215288
|
Heifets L et al. |
Mycobacterium avium strains resistant to clarithromycin and azithromycin. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8031351
|
Fass RJ |
Erythromycin, clarithromycin, and azithromycin: use of frequency distribution curves, scattergrams, and regression analyses to compare in vitro activities and describe cross-resistance. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8257127
|
Gomberg MA and MashkilleÄson AL |
[Use of azithromycin in long existing urogenital chlamydia infections and its association with primary syphilis]. |
1993 |
Antibiot. Khimioter. |
pmid:8060178
|
Sidorenko SV |
[Azithromycin--an antibiotic of the azalide group]. |
1993 |
Antibiot. Khimioter. |
pmid:8060181
|
Lopatkin NA et al. |
[Use of azithromycin ("Sumamded") in the treatment of infectious-inflammatory diseases of the lower urinary tract and male genitalia]. |
1993 |
Antibiot. Khimioter. |
pmid:8060189
|
Saba J et al. |
Pyrimethamine plus azithromycin for treatment of acute toxoplasmic encephalitis in patients with AIDS. |
1993 |
Eur. J. Clin. Microbiol. Infect. Dis. |
pmid:8112357
|
Weiss LM et al. |
Efficacy of azithromycin for treating Babesia microti infection in the hamster model. |
1993 |
J. Infect. Dis. |
pmid:8228366
|
Lefèvre JC et al. |
In vitro evaluation of activities of azithromycin, clarithromycin and sparfloxacin against Chlamydia trachomatis. |
1993 |
Pathol. Biol. |
pmid:8233628
|
Agacfidan A et al. |
In vitro activity of azithromycin (CP-62,993) against Chlamydia trachomatis and Chlamydia pneumoniae. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8239579
|
Tomazic J et al. |
In vivo administration of azithromycin affects lymphocyte activity in vitro. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8239585
|
Cantin L and Chamberland S |
In vitro evaluation of the activities of azithromycin alone and combined with pyrimethamine against Toxoplasma gondii. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8239619
|
Meyer AP et al. |
Uptake of azithromycin by human monocytes and enhanced intracellular antibacterial activity against Staphylococcus aureus. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8285612
|
Lalak NJ and Morris DL |
Azithromycin clinical pharmacokinetics. |
1993 |
Clin Pharmacokinet |
pmid:8287632
|
Saverino D et al. |
Plasmid loss from gram-negative bacteria exposed to subinhibitory concentrations of beta-lactam drugs and azithromycin. |
1993 |
New Microbiol. |
pmid:8264424
|
Pajukanta R |
In vitro antimicrobial susceptibility of Porphyromonas gingivalis to azithromycin, a novel macrolide. |
1993 |
Oral Microbiol. Immunol. |
pmid:8265209
|
Gage TW |
New drugs from 1991-1992. |
1993 |
Tex Dent J |
pmid:8273018
|
Spangler SK and Appelbaum PC |
Oxyrase, a method which avoids CO2 in the incubation atmosphere for anaerobic susceptibility testing of antibiotics affected by CO2. |
1993 |
J. Clin. Microbiol. |
pmid:8381817
|
Rodewald LE and Pichichero ME |
Compliance with antibiotic therapy: a comparison of deuterium oxide tracer, urine bioassay, bottle weights, and parental reports. |
1993 |
J. Pediatr. |
pmid:8391566
|
de Górgolas Hernández-Mora M et al. |
[Therapeutic approaches to cryptosporidiosis. A review of the literature]. |
1993 |
Rev Clin Esp |
pmid:8259458
|
Vargas SL et al. |
Azithromycin for treatment of severe Cryptosporidium diarrhea in two children with cancer. |
1993 |
J. Pediatr. |
pmid:8391567
|
Berger BW |
Lyme disease. |
1993 |
Semin Dermatol |
pmid:8312152
|
O'Connell S et al. |
Chronic active toxoplasmosis in an immunocompetent patient. |
1993 |
J. Infect. |
pmid:8308325
|
Gingras BA and Jensen JB |
Antimalarial activity of azithromycin and erythromycin against Plasmodium berghei. |
1993 |
Am. J. Trop. Med. Hyg. |
pmid:8394660
|
Mansoor GA et al. |
Azithromycin-induced acute interstitial nephritis. |
1993 |
Ann. Intern. Med. |
pmid:8395778
|
Guerra LG et al. |
Rapid response of AIDS-related bacillary angiomatosis to azithromycin. |
1993 |
Clin. Infect. Dis. |
pmid:8399879
|
Workowski KA et al. |
Azithromycin in chlamydial urethritis. |
1993 |
JAMA |
pmid:8411548
|
Genç M et al. |
An economic evaluation of screening for Chlamydia trachomatis in adolescent males. |
1993 |
JAMA |
pmid:8411572
|
DÃaz Sánchez M et al. |
[New medications: azithromycin]. |
1993 Jul-Sep |
Rev Med Univ Navarra |
pmid:8134755
|
Odugbemi T et al. |
Single oral dose of azithromycin for therapy of susceptible sexually transmitted diseases: a multicenter open evaluation. |
1993 Jul-Sep |
West Afr J Med |
pmid:8312208
|
Minguez F et al. |
In vitro killing kinetics and postantibiotic effect of josamycin and other macrolides on several bacteria. |
1993 May-Jun |
Chemotherapy |
pmid:8389685
|
Weber K et al. |
Azithromycin versus penicillin V for the treatment of early Lyme borreliosis. |
1993 Nov-Dec |
Infection |
pmid:8132365
|
Scaglione F et al. |
A new model examining intracellular and extracellular activity of amoxicillin, azithromycin, and clarithromycin in infected cells. |
1993 Nov-Dec |
Chemotherapy |
pmid:8222870
|
Braga PC and Piatti G |
Interference by subinhibitory concentrations of azithromycin with the mechanism of bacterial adhesion to human epithelial cells. |
1993 Nov-Dec |
Chemotherapy |
pmid:8222872
|
Goldman MP and Longworth DL |
The role of azithromycin and clarithromycin in clinical practice. |
1993 Sep-Oct |
Cleve Clin J Med |
pmid:8403355
|
Benson C |
Advances in the diagnosis and treatment of Mycobacterium avium complex (MAC) disease. |
1994 |
AIDS Patient Care |
pmid:11362136
|
O'Day DM et al. |
Ocular pharmacokinetics of orally administered azithromycin in rabbits. |
1994 |
J Ocul Pharmacol |
pmid:7714407
|
Ishida K et al. |
In vitro and in vivo activities of macrolides against Mycoplasma pneumoniae. |
1994 |
Antimicrob. Agents Chemother. |
pmid:8031048
|
Tuffrey M et al. |
The effect of a single oral dose of azithromycin on chlamydial infertility and oviduct ultrastructure in mice. |
1994 |
J. Antimicrob. Chemother. |
pmid:7730241
|
Dorrell L et al. |
Intravenous azithromycin as salvage therapy in a patient with Legionnaire's disease. |
1994 |
Thorax |
pmid:8016806
|
Klepser ME et al. |
Treatment of uncomplicated infections caused by Chlamydia trachomatis and Neisseria gonorrhoeae. |
1994 |
Conn Med |
pmid:7924316
|
Wallace MR et al. |
Ototoxicity with azithromycin. |
1994 |
Lancet |
pmid:7904701
|
Klemens SP and Cynamon MH |
Intermittent azithromycin for treatment of Mycobacterium avium infection in beige mice. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7986001
|
Donowitz GR |
Tissue-directed antibiotics and intracellular parasites: complex interaction of phagocytes, pathogens, and drugs. |
1994 |
Clin. Infect. Dis. |
pmid:7893881
|
Andersen SL et al. |
Efficacy of azithromycin as a causal prophylactic agent against murine malaria. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7986022
|
Beale AS and Upshon PA |
Characteristics of murine model of genital infection with Chlamydia trachomatis and effects of therapy with tetracyclines, amoxicillin-clavulanic acid, or azithromycin. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7811001
|
Verdon MS et al. |
Pilot study of azithromycin for treatment of primary and secondary syphilis. |
1994 |
Clin. Infect. Dis. |
pmid:7811868
|
Cazzola M et al. |
Evaluation of lung tissue and hilar lymph node concentrations of azithromycin. |
1994 |
Int J Clin Pharmacol Ther |
pmid:8004364
|
Raszka WV et al. |
Multifocal M. intracellulare osteomyelitis in an immunocompetent child. |
1994 |
Clin Pediatr (Phila) |
pmid:7813141
|
Hughes WT et al. |
Relative potency of 10 drugs with anti-Pneumocystis carinii activity in an animal model. |
1994 |
J. Infect. Dis. |
pmid:7930735
|
Rehg JE |
A comparison of anticryptosporidial activity of paromomycin with that of other aminoglycosides and azithromycin in immunosuppressed rats. |
1994 |
J. Infect. Dis. |
pmid:7930738
|
Spangler SK et al. |
Effect of CO2 on susceptibilities of anaerobes to erythromycin, azithromycin, clarithromycin, and roxithromycin. |
1994 |
Antimicrob. Agents Chemother. |
pmid:8192445
|
Niki Y et al. |
In vitro and in vivo activities of azithromycin, a new azalide antibiotic, against chlamydia. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7840560
|
Stamler DA et al. |
Azithromycin pharmacokinetics and intracellular concentrations in Legionella pneumophila-infected and uninfected guinea pigs and their alveolar macrophages. |
1994 |
Antimicrob. Agents Chemother. |
pmid:8192446
|
Freeman CD et al. |
Intracellular and extracellular penetration of azithromycin into inflammatory and noninflammatory blister fluid. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7840585
|
Wildfeuer A et al. |
Distribution of orally administered azithromycin in various blood compartments. |
1994 |
Int J Clin Pharmacol Ther |
pmid:7952797
|
Bottaro G et al. |
[Evaluation of the clinical efficacy of azithromycin in acute respiratory infections in children]. |
1994 |
Clin Ter |
pmid:7955949
|
Sifrim D et al. |
Comparison of the effects of midecamycin acetate and azithromycin on gastrointestinal motility in man. |
1994 |
Drugs Exp Clin Res |
pmid:7956719
|
Dumas JL et al. |
Evaluation of the efficacy of prolonged administration of azithromycin in a murine model of chronic toxoplasmosis. |
1994 |
J. Antimicrob. Chemother. |
pmid:7961197
|
Wallace MR et al. |
Azithromycin and typhoid. |
1994 |
Lancet |
pmid:7911192
|
Mizukane R et al. |
Comparative in vitro exoenzyme-suppressing activities of azithromycin and other macrolide antibiotics against Pseudomonas aeruginosa. |
1994 |
Antimicrob. Agents Chemother. |
pmid:8203850
|
Carlier MB et al. |
Accumulation, release and subcellular localization of azithromycin in phagocytic and non-phagocytic cells in culture. |
1994 |
Int J Tissue React |
pmid:7558665
|
|
Management of genital Chlamydia trachomatis infections. |
1994 |
Drug Ther Bull |
pmid:7635012
|
Steven N et al. |
Corticosteroid therapy for AIDS patients with Mycobacterium avium-intracellulare infection. |
1994 |
AIDS |
pmid:8011231
|
Chiarini F et al. |
Chlamydia trachomatis genitourinary infections: laboratory diagnosis and therapeutic aspects. Evaluation of in vitro and in vivo effectiveness of azithromycin. |
1994 |
J Chemother |
pmid:7830100
|
Wang JH et al. |
Azithromycin in the treatment of pneumonia caused by Chlamydia pneumoniae: report of a case. |
1994 |
J. Formos. Med. Assoc. |
pmid:7866068
|
|
[Newly approved specialty drugs in Austria and new knowledge about currently available specialty drugs. Zithromax capsules, dried syrup]. |
1994 |
Wien. Klin. Wochenschr. |
pmid:7975673
|
Cynamon MH et al. |
Comparative activities of azithromycin and clarithromycin against Mycobacterium avium infection in beige mice. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7979270
|
Klemens SP and Cynamon MH |
Activities of azithromycin and clarithromycin against nontuberculous mycobacteria in beige mice. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7979271
|
Schönwald S et al. |
Three-day azithromycin compared with ten-day roxithromycin treatment of atypical pneumonia. |
1994 |
Scand. J. Infect. Dis. |
pmid:7747094
|
Schwab JC et al. |
Localization of azithromycin in Toxoplasma gondii-infected cells. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7979295
|
|
[Azithromycin--an innovative macrolide antibiotic for 3-day-therapy]. |
1994 |
Immun. Infekt. |
pmid:7982710
|
Rodriguez WJ and Wiedermann BL |
The role of newer oral cephalosporins, fluoroquinolones, and macrolides in the treatment of pediatric infections. |
1994 |
Adv Pediatr Infect Dis |
pmid:8123221
|
Eisenberg E and Barza M |
Azithromycin and clarithromycin. |
1994 |
Curr Clin Top Infect Dis |
pmid:8086122
|
Kanatani MS and Guglielmo BJ |
The new macrolides. Azithromycin and clarithromycin. |
1994 |
West. J. Med. |
pmid:8128699
|
Pfefferkorn ER and Borotz SE |
Comparison of mutants of Toxoplasma gondii selected for resistance to azithromycin, spiramycin, or clindamycin. |
1994 |
Antimicrob. Agents Chemother. |
pmid:8141576
|
Bermudez LE et al. |
Rifabutin and sparfloxacin but not azithromycin inhibit binding of Mycobacterium avium complex to HT-29 intestinal mucosal cells. |
1994 |
Antimicrob. Agents Chemother. |
pmid:8067766
|
Uzun O et al. |
Efficacy of a three-day course of azithromycin in the treatment of community-acquired pneumococcal pneumonia. Preliminary report. |
1994 |
J Chemother |
pmid:8071680
|
Marchi M et al. |
[Azithromycin-omeprazole. Treatment for the eradication of Helicobacter pylori]. |
1994 |
Minerva Gastroenterol Dietol |
pmid:8204705
|
Benson CA |
Treatment of disseminated disease due to the Mycobacterium avium complex in patients with AIDS. |
1994 |
Clin. Infect. Dis. |
pmid:8204776
|
Parent M |
[Initial empiric treatment of pneumonia and the new antibiotics]. |
1994 |
Union Med Can |
pmid:8109061
|
Bosatra A et al. |
[Effectiveness of and tolerance to azithromycin versus roxithromycin in the treatment of patients with acute infections of the upper respiratory tract]. |
1994 |
Clin Ter |
pmid:8168348
|
Kuschner RA et al. |
Azithromycin prophylaxis against a chloroquine-resistant strain of Plasmodium falciparum. |
1994 |
Lancet |
pmid:7910886
|
Rakita RM et al. |
Intracellular activity of azithromycin against bacterial enteric pathogens. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7810998
|
Bermudez LE et al. |
Recombinant granulocyte-macrophage colony-stimulating factor enhances the effects of antibiotics against Mycobacterium avium complex infection in the beige mouse model. |
1994 |
J. Infect. Dis. |
pmid:8158029
|
Rehg J |
New potential therapies for cryptosporidiosis: an analysis of variables affecting drug efficacy. |
1994 |
Folia Parasitol. |
pmid:8050751
|
Godofsky EW |
Treatment of presumed cerebral toxoplasmosis with azithromycin. |
1994 |
N. Engl. J. Med. |
pmid:8302335
|
Rapp RP et al. |
New macrolide antibiotics: usefulness in infections caused by mycobacteria other than Mycobacterium tuberculosis. |
1994 |
Ann Pharmacother |
pmid:7849341
|